Complete Genomics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments ...

BGI had reached an agreement to acquire genome technology firm Complete Genomics Inc. for $117.6 million in September, the first-ever acquisition of a U.S.

... of the U.S. drilling operations of Canada's Nexen Inc; auto-parts company Wanxiang Group's successful $257 million bankruptcy-auction bid for electric-battery maker A123 Systems Inc; BGI-Shenzhen's purchase of California-based Complete Genomics Inc ...

They have incredible software tools, they have an incredible database, clinical phenotype database and there's an enormous understanding of the genetics, of the genomics and the phenotypic clinical data across the population in Iceland. And that ...

Illumina, Inc. (NASDAQ:ILMN) today announced the full commercial availability of BaseSpace, the Company's genomics cloud computing and storage platform. BaseSpace Apps is now out of beta status, and includes a full-fledged e-commerce system that ...

Last month, in a bid to strengthen its contraceptive portfolio, Bayer (BAYRY) inked a deal to buy contraceptive device-maker Conceptus Inc. (CPTS) for approximately $1.1 billion in cash. This impending acquisition will add the Essure permanent (non ...

But with the new immunotherapy, �four out of five children treated to date have had complete remissions,� he said. The treatment works fast.

OpGen, Inc. today announced that new data on the utility and application of its Whole Genome Mapping(TM) technology in the public health and health care settings will be highlighted at a company-sponsored symposium and poster presentation during the ...

Agilent Technologies Inc. (NYSE:A) today reported orders of $1.69 billion, down 8 percent compared with one year ago, and revenues of $1.73 billion for the second fiscal quarter ended April 30, 2013, flat with one year ago.

In the Complete Genomics ruling, Vice Chancellor J. Travis Laster preliminarily enjoined the enforcement of a standstill agreement containing a �don't ask, don't waive� provision.